Skip to main content

Invitrogen Wins US Patent for Dry Cell-Culture Medium

NEW YORK, May 23 - Invitrogen said today it has won a patent in the US for a dry form of cell culture medium.


The patent, No.6,383,810, covers what the company calls Advanced Granulation Technology, which Invitrogen claims is a medium that "produces specific ionic and pH conditions" when reconstituted in water.


AGT media "do not require additional supplementation or pH adjustment ... and reduce he potential for scrap during media preparation," the company said.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.